Chromatin and transcriptome remodeling under EGFR chemical inhibition in lung cancer (RNA-seq)

ABSTRACT: We present paired ATAC and RNA-sequencing from EGFR-driven lung cancer cell lines genetically engineered to lose the tumor suppressors RB1 or RB1 with PTEN, and study the acute response of these cell lines to FDA-approved chemical inhibitors of EGFR

ORGANISM(S): Homo sapiens

PROVIDER: GSE140941 | GEO | 2021/06/01

REPOSITORIES: GEO